NL2038129B1 - An Interventional Optical Neural Stimulation Device - Google Patents
An Interventional Optical Neural Stimulation Device Download PDFInfo
- Publication number
- NL2038129B1 NL2038129B1 NL2038129A NL2038129A NL2038129B1 NL 2038129 B1 NL2038129 B1 NL 2038129B1 NL 2038129 A NL2038129 A NL 2038129A NL 2038129 A NL2038129 A NL 2038129A NL 2038129 B1 NL2038129 B1 NL 2038129B1
- Authority
- NL
- Netherlands
- Prior art keywords
- module
- light source
- fiber
- optical
- interventional
- Prior art date
Links
- 230000003287 optical effect Effects 0.000 title claims abstract description 66
- 230000000638 stimulation Effects 0.000 title claims abstract description 64
- 230000001537 neural effect Effects 0.000 title claims abstract description 37
- 230000005540 biological transmission Effects 0.000 claims abstract description 52
- 210000004556 brain Anatomy 0.000 claims abstract description 41
- 239000000835 fiber Substances 0.000 claims description 72
- 239000010410 layer Substances 0.000 claims description 47
- 230000008878 coupling Effects 0.000 claims description 18
- 238000010168 coupling process Methods 0.000 claims description 18
- 238000005859 coupling reaction Methods 0.000 claims description 18
- 239000011241 protective layer Substances 0.000 claims description 17
- 210000004204 blood vessel Anatomy 0.000 claims description 10
- 229910001069 Ti alloy Inorganic materials 0.000 claims description 8
- 238000005452 bending Methods 0.000 claims description 6
- 239000011669 selenium Substances 0.000 claims description 6
- 238000005253 cladding Methods 0.000 claims description 3
- 238000004519 manufacturing process Methods 0.000 claims description 3
- 239000000463 material Substances 0.000 claims description 3
- 229910052711 selenium Inorganic materials 0.000 claims description 3
- 239000013598 vector Substances 0.000 claims description 3
- 125000003748 selenium group Chemical group *[Se]* 0.000 claims 1
- 238000011160 research Methods 0.000 abstract description 6
- 238000010586 diagram Methods 0.000 description 11
- 238000000034 method Methods 0.000 description 10
- 241001494479 Pecora Species 0.000 description 8
- 238000002474 experimental method Methods 0.000 description 6
- 238000005516 engineering process Methods 0.000 description 5
- 239000000956 alloy Substances 0.000 description 4
- 230000006399 behavior Effects 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 2
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 2
- 241001125929 Trisopterus luscus Species 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 230000000644 propagated effect Effects 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 210000003625 skull Anatomy 0.000 description 2
- 241000252212 Danio rerio Species 0.000 description 1
- 208000001654 Drug Resistant Epilepsy Diseases 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 238000002583 angiography Methods 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 230000035045 associative learning Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000012292 cell migration Effects 0.000 description 1
- 238000013480 data collection Methods 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 230000005611 electricity Effects 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 230000034659 glycolysis Effects 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 230000001418 larval effect Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 230000005389 magnetism Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000004770 neurodegeneration Effects 0.000 description 1
- 208000015122 neurodegenerative disease Diseases 0.000 description 1
- 210000002569 neuron Anatomy 0.000 description 1
- 208000020016 psychiatric disease Diseases 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 230000002123 temporal effect Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N5/0613—Apparatus adapted for a specific treatment
- A61N5/0622—Optical stimulation for exciting neural tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N5/0601—Apparatus for use inside the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N5/067—Radiation therapy using light using laser light
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/063—Radiation therapy using light comprising light transmitting means, e.g. optical fibres
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/0658—Radiation therapy using light characterised by the wavelength of light used
- A61N2005/0659—Radiation therapy using light characterised by the wavelength of light used infrared
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Radiology & Medical Imaging (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Pathology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- Biophysics (AREA)
- Neurosurgery (AREA)
- Laser Surgery Devices (AREA)
- Radiation-Therapy Devices (AREA)
Abstract
An Interventional Optical Neural Stimulation Device The present invention belongs to the interdisciplinary research field of biophotonics and involves an interventional optical neural stimulation device. The device comprises a light source generation module, a transmission guidance module, and an optical stimulation terminal module; the light source generation module is used to generate a light source with specific wavelength, power, pulse period, and pulse width according to actual requirements, coupled into the transmission guidance module; the transmission guidance module serves as a medium connecting the light source generation module and the optical stimulation terminal module, accepting the laser beam generated by the light source generation module and guiding it to the designated brain area of the target biological organism; the optical stimulation terminal module is used to fix the laser beam transmitted by the transmission guidance module in a pre-specified target brain area of the biological organism.
Description
An Interventional Optical Neural Stimulation Device
The present invention belongs to the interdisciplinary research field of biophotonics in biology, involving an interventional optical neural stimulation device.
Photonics biology is a discipline that studies the interaction between light and biological organisms, utilizing light (photons) to image, detect, and manipulate biological materials. In this field, various forms of neural modulation such as light, electricity, magnetism, and sound have been extensively researched by the academic community and applied clinically to treat brain functional disorders such as mental illnesses, drug-resistant epilepsy, and neurodegenerative diseases. In the realm of optogenetics and mid-infrared modulation techniques, significant progress has been made in recent years.
Optogenetics involves introducing exogenous light-sensitive proteins into specific living cells using viruses and stimulating these proteins with light of specific wavelength, power, pulse period, and pulse width to modulate neuronal activity, control cell behavior, and even animal behavior. This technology offers excellent characteristics such as high sensitivity, low toxicity, millisecond-level temporal accuracy, subcellular spatial precision, enabling researchers to explore the interconnections of various neurons and brain region functions, opening up new frontiers in brain science and neurobiology research.
Mid-infrared modulation is a promising modulation method applicable in clinical settings, exerting regulatory effects on neuronal signals and behaviors, possessing non-thermal, long- distance, and reversible qualities. This technology has been shown to inhibit cancer cell migration and glycolysis regulation, with research results in live experiments showing accelerated associative learning in mice and modulation of zebrafish larval neuronal activity, demonstrating significant research potential.
Current implementations of light excitation or mid-infrared modulation in optogenetics require special procedures such as opening the animal's brain, removing the skull, or thinning the skull, causing significant damage to experimental animals, hindering live experiments and obtaining stable and reliable experimental data, and failing to provide long-term, stable, and sustainable experimental conditions.
The present invention provides an interventional optical neural stimulation device to address the difficulty in achieving experimental conditions for optical neural stimulation in existing technologies, providing an experimental platform for optical neural stimulation and other biophotonics research.
To achieve the above objectives, the present invention adopts the following technical solution:
An interventional optical neural stimulation device comprising a light source generation module, a transmission guidance module, and an optical stimulation terminal module;
The light source generation module is used to generate a light source of specific wavelength, power, pulse period, and pulse width according to actual requirements, coupled into the transmission guidance module;
The transmission guidance module serves as a medium to connect the light source generation module and the optical stimulation terminal module, receiving the laser beam generated by the light source generation module and guiding it to the designated brain area of the target organism;
The optical stimulation terminal module is used to fix the laser beam transmitted by the transmission guidance module in the pre-specified target brain area of the target organism.
In a further improved embodiment of this technical solution, the light source generation module comprises a light source, an attenuating section, and a coupling part; wherein, the light source, attenuating section, and coupling part are connected via a collimated light path: the light source emits a laser beam of a specified wavelength, pulse period, and pulse width, obtains a laser beam of specified power after passing through the attenuating section, and couples into the transmission guidance module at the coupling part.
In a further improved embodiment of this technical solution, the light source and the attenuating section are detachably connected.
In a further improved embodiment of this technical solution, the coupling part is a mechanical device fixed to the first end of the transmission guidance module, with an internal groove structure and a surface protrusion that fits the first end of the transmission guidance module, horizontally fixed with a nut.
In a further improved embodiment of this technical solution, the transmission guidance module comprises a fiber layer, a support layer, and a protective layer; wherein, the support layer and the protective layer tightly wrap around the fiber layer from the inner layer to the outer layer, and the resulting transmission guidance module is implanted along a pre-designed path in the blood vessels of the target organism's brain, with its end combined with the optical stimulation terminal module.
In a further improved embodiment of this technical solution, the support layer is made of titanium alloy material with a collapsible mesh structure, with a diameter less than 0.8mm when collapsed; the protective layer is a microtube with a diameter of 1mm; the fiber layer is an IRF-Se series selenium-based infrared fiber with a diameter of 100um and a numerical aperture of 0.27.
In a further improved embodiment of this technical solution, the optical stimulation terminal module comprises a fiber end and a supporting stent, with the fiber end fixed inside the supporting stent; wherein, the fiber end is the fiber tail of the fiber layer, and the supporting stent is a titanium alloy mesh structure with extensibility and collapsibility.
In a further improved embodiment of this technical solution, the supporting stent has a collapsing diameter smaller than the inner diameter of the protective layer.
In a further improved embodiment of this technical solution, the final emitted power Poyr at the end of the optical neural stimulation device satisfies:
Pout = Ro + (py, Bm, A) +10 10°
Where P‚ut and P, represent the output power and the power of the input fiber layer, respectively; the term 102 describes the attenuation of the beam in the fiber layer, a indicating the fiber's loss coefficient; (ny: 61, A) describes the attenuation from the light source to the coupling into the fiber layer, for the case of Gaussian beam incidence, it can be expressed as: erf Ce (ny, ben A) = Tero] * 1)
Where w‚y represents the near-field width of the laser beam, A is the wavelength of the beam, 6. is the numerical aperture of the fiber, erf is the error function, and 1 represents the reflection loss at the fiber end;
The loss coefficient a comes from transmission losses due to the optical material and manufacturing, as well as bending during use, considering macro-bending losses since the transmission guidance module needs to enter the blood vessels of the target organism's brain, macro-bending loss is considered: ak? TT Gn)
GXP [2 B* n;koa 7 R] [R/B2 — n5k3a2k3(n? — n3)
Where a is the core radius, n; and n, are the refractive indices of the core and cladding, k and kg are the wave vectors of light in the fiber and in vacuum, B is the propagation constant, R is the curvature radius of the fiber bend.
In contrast to existing technologies, the above technical solution has the following beneficial effects: the present invention provides an interventional optical neural stimulation device that achieves optical stimulation of designated brain areas in organisms in a minimally invasive manner.
The interventional approach reduces the damage caused to organisms in existing technologies to achieve optical neural stimulation, with the stimulation location inside the biological brain area, ensuring the effectiveness of stimulation and the accuracy of subsequent data collection; by following a designated path along the blood vessels of the biological brain area, precise stimulation of the designated area by the beam is achieved; the light source and attenuator can be replaced according to actual requirements, outputting a laser beam of specific wavelength, power, pulse period, and pulse width, suitable for optical stimulation experiments under different conditions; the transmission guidance module has a certain extensibility, and its specifications can be adjusted within a certain range with the optical stimulation terminal module, making it suitable for biological experiments on different brain structures, with strong universality; additionally, the support is made of titanium alloy material, which has good biocompatibility, reducing the exclusion of biological tissues.
Figure 1 is a schematic diagram of the structure of the interventional optical neural stimulation device;
Figure 2 is a schematic diagram of the light source generation module;
Figure 3 is a schematic diagram of the transmission guidance module;
Figure 4 is a sectional schematic diagram of the transmission guidance module;
Figure 5 is a schematic diagram of the optical stimulation terminal module;
Figure 6 is a top view schematic diagram of interventional optical neural stimulation through sheep brain blood vessels.
Reference signs:
Light source generation module 1; Light source 11; Attenuating section 12; Coupling part 13; Transmission guidance module 2; Fiber layer 21; Support layer 22; Protective layer 23; Optical stimulation terminal module 3; Fiber end 31; Supporting stent 32.
To explain the technical content, structural features, achieved objectives, and effects of the technical solution in detail, specific embodiments are described below with detailed explanations and accompanying drawings.
As shown in Figure 1, a schematic diagram of the structure of the interventional optical neural stimulation device. The interventional optical neural stimulation device provided by the present invention includes sequentially connected light source generation module 1, transmission guidance module 2, and optical stimulation terminal module 3. The light source generation module 1 is used to generate a light source of specific wavelength, power, pulse period, and pulse width according to actual requirements, coupled into the transmission guidance module 2. The transmission guidance module 2 serves as a medium to connect the light source generation 5 module and the optical stimulation terminal module, receiving the laser beam generated by the light source generation module and guiding it to the designated brain area of the target organism. The optical stimulation terminal module 3 is used to fix the laser beam transmitted by the transmission guidance module in the pre-specified target brain area of the target organism.
The light source generation module 1 includes a light source 11, an attenuating section 12, and a coupling part 13.
The transmission guidance module 2 includes a fiber layer 21, a support layer 22, and a protective layer 23.
The optical stimulation terminal module 3 includes a fiber end 31 and a supporting stent 32.
As shown in Figure 2, a schematic diagram of the light source generation module. The light source generation module 1 includes a light source 11, an attenuating section 12, and a coupling part 13. The light source 11 is a tunable laser that supports different wavelengths, pulse periods, and pulse widths output according to actual wavelength requirements; the attenuating section 12 is a device that can attenuate the laser beam selected according to actual power requirements, such as an attenuator or a power adjustment device built into the laser; the coupling part 13 is a mechanical device fixed to the first end of the transmission guidance module 2, with an internal groove structure, a surface protrusion that fits the first end of the transmission guidance module 2, and is horizontally fixed with a nut.
The light source 11, attenuating section 12, and coupling part 13 are connected via a collimated light path: the light source 11 emits a laser beam of a specified wavelength, obtains a laser beam of specified power after passing through the attenuating section 12, and couples into the fiber layer 21 of the transmission guidance module 2 at the coupling part 13. The light source 11 and the attenuating section 12 are detachable and can be replaced according to actual requirements. In this embodiment, the light source 11 uses a quantum cascade mid-infrared laser with a wide wavelength range and easy integration to generate mid-infrared beam, the attenuating section 12 uses an attenuator to output laser beam power at the mW level at the fiber end, and the coupling part 13 is a mechanical device fixed to the first end of the transmission guidance module 2, with an internal groove structure, a surface protrusion that fits the first end of the transmission guidance module 2, and is horizontally fixed with a nut. The light source 11 and the attenuating section 12 are detachable and can be replaced according to actual requirements. The actual requirements refer to the optical parameters that the light source should have when using this device for optical neural stimulation.
As shown in Figure 3, a schematic diagram of the transmission guidance module. The specifications of the support layer 22, protective layer 23, and fiber layer 21 of the transmission guidance module 2 can be customized according to actual requirements; in this embodiment, the support layer 22 is made of titanium alloy material with a collapsible mesh structure, with a diameter less than 0.8mm when collapsed, the protective layer 23 is a microtube with a diameter of 1mm, and the fiber layer 21 is an IRF-Se series selenium-based infrared fiber with a diameter of 100um and a numerical aperture of 0.27. Referring to the sectional schematic diagram of the transmission guidance module shown in Figure 4, the support layer 22 and the protective layer 23 tightly wrap around the fiber layer 21 from the inner layer to the outer layer, and the resulting transmission guidance module 2 has a certain extensibility, allowing it to be implanted along a pre- designed path in the blood vessels of the target organism's brain, with its end combined with the optical stimulation terminal module 3, ensuring that the fiber end 31 is close to the designated biological brain area.
The transmission guidance module 2 includes a fiber layer 21, a support layer 22, and a protective layer 23. The fiber layer 21 is a fiber with a specified working window and supporting a specific mode selected according to actual requirements; the support layer 22 is made of titanium alloy material, connected to the supporting stent 32 at the tail end; the protective layer 23 is a microtube with a diameter larger than the collapsed diameter of the supporting stent 32. The transmission guidance module 2 has a certain extensibility and can navigate through the nonlinear biological brain blood vessel structure.
As shown in Figure 5, a schematic diagram of the optical stimulation terminal module. The supporting stent 32, with its mesh metal structure fitting the blood vessel wall of the biological brain area, has a groove on the inner side to fix the fiber end 31; the fiber end 31 emits the laser beam propagated from the fiber layer 21 ata set angle to stimulate the designated brain area. The optical stimulation terminal module 3 includes a fiber end 31 and a supporting stent 32. The fiber end 31 is the fiber tail of the fiber layer 21, and the supporting stent 32 is a titanium alloy mesh structure with extensibility and collapsibility.
The supporting stent 32, when not expanded, is wrapped inside the protective layer 23.
Before optical neural stimulation, by pulling the protective layer 23 outward, the supporting stent 32 naturally expands, fitting the blood vessel wall of the biological brain area with its mesh metal structure, with a groove on the inner side to fix the fiber end 31; the fiber end 31 emits the laser beam propagated from the fiber layer 21 at a set angle to stimulate the designated brain area.
The specifications of the transmission guidance module 2 and the optical stimulation terminal module 3 can be customized within a certain range; in the application scenarios of the present invention, different organisms have individual differences, with varying brain vessel structures, distributions, and diameters, and different designated brain area positions during specific experiments, suitable specifications can be selected according to actual requirements. The actual requirements refer to the specification parameters required to reach the target brain area for neural stimulation and meet the requirements of the vascular structure and application during specific experiments.
In practical applications, the optical neural stimulation effect is highly related to the wavelength and optical power; after determining the wavelength of the light source, the selection of the light source generation module, attenuating section, and fiber layer should prioritize the final emitted power.
Regarding the power attenuation issue of the fiber optic output, the interventional optical neural stimulation device ensures that the final emitted power Py at the fiber end 31 meets: ~axLy
Pout = Pin * f{wpy, 8,m, A) * 10710
Where Pu and Pi, are the output power and the power into the fiber layer 21 respectively; the term 1052 describes the attenuation of the beam in the fiber layer 21, a indicating the fiber's loss coefficient; (ny; ben, A) describes the attenuation from the light source 11 to coupling into the fiber layer 21, for the case of Gaussian beam incidence, it can be expressed as: erf CN (ny, bn, A) = Tele] #1)
Where w,, represents the laser beam's near-field width, A is the beam's wavelength, 6; is the aperture angle of the fiber, erf is the error function, and 1 is the reflection loss of the fiber end face.
The loss coefficient a comes from transmission losses generated by optical materials and manufacturing, as well as bending during use. Since the transmission guidance module 2 needs to enter the target biological brain vessels, macro-bending losses need to be considered, especially for multimode fibers: ak? - 2 (92 — ng)?
A= nn exp [2 |B? - n;kga —=——p7—R]
JR/B? — njkja?kj(nî — nd)
Where a is the core radius, n: and n2 are the refractive indices of the core and cladding, k and ko are the wave vectors in the fiber and vacuum, B is the propagation constant, R is the radius of curvature of the fiber bend, similar results apply for single-mode fibers.
In this embodiment, the selected biological target for optical neural stimulation is a sheep.
The light beam output by the light source generation module 1 based on the required optical parameters is coupled into the transmission guidance module 2, which is pre-implanted along a specified path within the sheep's brain vessels to reach the designated brain area. The optical stimulation terminal module 3 expands the titanium support frame and attaches it to the vessel wall, fixing the beam end near the designated brain area's vessel, allowing the beam to act on the target brain area at a specified angle.
As shown in Figure 6, a top view schematic of interventional optical neural stimulation through sheep brain vessels. After selecting the sheep brain area for optical neural stimulation, based on techniques like angiography, the structure of the sheep's brain vessels in the target area is obtained to determine the path of the transmission guidance module 2 to reach the vessels near the sheep's brain area; an incision is made at the specified vessel position, and the transmission guidance module 2 is pushed into the vessel from the incision, adhering to the vessel wall along the specified path to reach the target position.
As shown in Figure 6, after removing the microcatheter, the supporting stent 32 of the optical stimulation terminal module 3 naturally expands, closely adhering to the vessel wall, and the fiber end 31 emits the beam at a specified angle, acting on the specific brain area of the sheep.
It should be noted that in this document, terms such as "first" and "second" are used merely to distinguish one entity or operation from another, without necessarily implying any actual relationship or order between these entities or operations. Additionally, terms like "comprising," "including," or any variations thereof are intended to encompass non-exclusive inclusion, such that a process, method, item, or terminal device comprising a series of elements includes not only those elements explicitly listed but also other elements not explicitly listed but inherent to the process, method, item, or terminal device. Without further limitations, elements limited by the phrases "comprising..." or "including..." do not exclude additional elements in the process, method, item, or terminal device that includes these elements. Furthermore, in this document, terms like "greater than," "less than," "exceeding" are understood to exclude the number itself; terms like "above," "below," "within" are understood to include the number.
Although the above embodiments have been described, once those skilled in the art are aware of the basic creative concept, they may make additional changes and modifications to these embodiments. Therefore, the above description is only an embodiment of the present invention and does not limit the scope of the patent protection of the present invention. Any equivalent structural or procedural changes made using the specification and drawings of the present invention, or directly or indirectly applied in other related technical fields, are also included within the scope of the patent protection of the present invention.
Claims (9)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202311647333.9A CN117563149A (en) | 2023-12-04 | 2023-12-04 | An interventional optical nerve stimulation device |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NL2038129A NL2038129A (en) | 2024-09-18 |
| NL2038129B1 true NL2038129B1 (en) | 2025-02-11 |
Family
ID=89895454
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NL2038129A NL2038129B1 (en) | 2023-12-04 | 2024-07-03 | An Interventional Optical Neural Stimulation Device |
Country Status (4)
| Country | Link |
|---|---|
| CN (1) | CN117563149A (en) |
| BE (1) | BE1031381B1 (en) |
| LU (1) | LU507674B1 (en) |
| NL (1) | NL2038129B1 (en) |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8792978B2 (en) * | 2010-05-28 | 2014-07-29 | Lockheed Martin Corporation | Laser-based nerve stimulators for, E.G., hearing restoration in cochlear prostheses and method |
| EP3589208A1 (en) * | 2017-03-02 | 2020-01-08 | Circuit Therapeutics, Inc. | System for optogenetic therapy |
| US12127957B2 (en) * | 2018-12-06 | 2024-10-29 | Universiteit Gent | Method for integrating an electronic circuit in or on a stent |
-
2023
- 2023-12-04 CN CN202311647333.9A patent/CN117563149A/en active Pending
-
2024
- 2024-07-03 NL NL2038129A patent/NL2038129B1/en active
- 2024-07-05 LU LU507674A patent/LU507674B1/en active IP Right Grant
- 2024-07-05 BE BE20245425A patent/BE1031381B1/en active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| LU507674B1 (en) | 2025-01-06 |
| BE1031381A1 (en) | 2024-09-19 |
| CN117563149A (en) | 2024-02-20 |
| BE1031381B1 (en) | 2025-04-01 |
| NL2038129A (en) | 2024-09-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1811901B1 (en) | Intravascular ultrasound imaging device | |
| Reddy et al. | Parylene photonics: a flexible, broadband optical waveguide platform with integrated micromirrors for biointerfaces | |
| EP1526800B1 (en) | Scanning miniature optical probes with optical distortion correction and rotational control | |
| KR102132145B1 (en) | Light diffusing devices for use in photoimmunotherapy | |
| Helmchen | Miniaturization of fluorescence microscopes using fibre optics | |
| Jung et al. | Numerical analysis of gradient index lens–based optical coherence tomography imaging probes | |
| Yu et al. | Micro-and nano-fiber probes for optical sensing, imaging, and stimulation in biomedical applications | |
| Pashaie et al. | Single optical fiber probe for fluorescence detection and optogenetic stimulation | |
| US10561303B2 (en) | Optical probes with correction components for astigmatism correction | |
| Astratov et al. | Photonic nanojets for laser surgery | |
| CN109901279A (en) | Microsphere self-assembled laser based on coaxial three-waveguide fiber | |
| JP2018000867A (en) | Catheter tube | |
| Yang et al. | A phase-shifted surface plasmon resonance sensor for simultaneous photoacoustic volumetric imaging and spectroscopic analysis | |
| US20140160482A1 (en) | Optical system for endoscopic internally-referenced interferometric imaging, and method for employing the same | |
| Tsakas et al. | Review of optical fiber technologies for optogenetics | |
| Qin et al. | Multichannel fiber photometry for mapping axonal terminal activity in a restricted brain region in freely moving mice | |
| NL2038129B1 (en) | An Interventional Optical Neural Stimulation Device | |
| Fichera | Bringing the light inside the body to perform better surgery | |
| Bijoch et al. | Novel design and application of high-NA fiber imaging bundles for In vivo brain imaging with two-photon scanning fluorescence microscopy | |
| AU2020101132A4 (en) | A multi-core optical fiber cellular laser system with stretching function | |
| US9411103B2 (en) | Contact focusing hollow-core fiber microprobes | |
| Chin et al. | Optical fiber sensors for biomedical applications | |
| Batista et al. | Two-photon imaging for non-invasive corneal examination | |
| Mohanty et al. | A reconfigurable nanophotonics platform for sub-millisecond, deep brain neural stimulation | |
| Baykal | Adaptive optics correction of beam spread in biological tissues |